Publisher: Wiley-Blackwell

Related content
Volume 13, Number 10, 1 October 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Lentiviral vector‐mediated knockdown of SOCS3 in the hypothalamus protects against the development of diet‐induced obesity in rats
pp. 885-892(8)
Authors: Liu, Z.‐J.; Bian, J.; Zhao, Y.‐L.; Zhang, X.; Zou, N.; Li, D.

Favourites:Add to Favourites

Metabolic effects of muraglitazar in type 2 diabetic subjects
pp. 893-902(10)
Authors: Fernandez, M.; Gastaldelli, A.; Triplitt, C.; Hardies, J.; Casolaro, A.; Petz, R.; Tantiwong, P.; Musi, N.; Cersosimo, E.; Ferrannini, E.; DeFronzo, R. A.

Favourites:Add to Favourites

Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
pp. 903-910(8)
Authors: Li, C.; Bowe, J. E.; Huang, G. C.; Amiel, S. A.; Jones, P. M.; Persaud, S. J.

Favourites:Add to Favourites

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet‐induced obese rats
pp. 911-920(10)
Authors: Feigh, M.; Henriksen, K.; Andreassen, K. V.; Hansen, C.; Henriksen, J. E.; Beck‐Nielsen, H.; Christiansen, C.; Karsdal, M. A.

Favourites:Add to Favourites

Cardiovascular outcomes associated with a new once‐weekly GLP‐1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
pp. 921-927(7)
Authors: Peskin, B. R.; Shcheprov, A. V.; Boye, K. S.; Bruce, S.; Maggs, D. G.; Gaebler, J. A.

Favourites:Add to Favourites

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase‐4 inhibitor linagliptin
pp. 939-946(8)
Authors: Graefe‐Mody, U.; Friedrich, C.; Port, A.; Ring, A.; Retlich, S.; Heise, T.; Halabi, A.; Woerle, H.‐J.

Favourites:Add to Favourites

Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes
pp. 959-962(4)
Authors: Hussey, S. E.; McGee, S. L.; Garnham, A.; Wentworth, J. M.; Jeukendrup, A. E.; Hargreaves, M.

Favourites:Add to Favourites

Phentermine therapy for obesity does not elevate blood pressure
pp. 963-964(2)
Authors: Hendricks, E. J.; Rothman, R. B.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more